Connection
Amrut Ambardekar to Cytomegalovirus
This is a "connection" page, showing publications Amrut Ambardekar has written about Cytomegalovirus.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.263 |
|
|
|
-
Concannon K, Page R, Swayngim R, Ambardekar AV, Chiu CY, Schoeppler K, Sartain E. Low-Dose Valganciclovir for Primary Cytomegalovirus Prophylaxis After Heart Transplant: A 10-Year Experience. Clin Transplant. 2025 Dec; 39(12):e70408.
Score: 0.223
-
Oreschak K, Saba LM, Rafaels N, Ambardekar AV, Deininger KM, PageII R, Lindenfeld J, Aquilante CL. Variants in mycophenolate and CMV antiviral drug pharmacokinetic and pharmacodynamic genes and leukopenia in heart transplant recipients. J Heart Lung Transplant. 2021 09; 40(9):917-925.
Score: 0.041